openPR Logo
Press release

Atrial Septal Defect Market Future Opportunities2017 - 2025

04-17-2018 11:00 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Atrial Septal Defect Market Future Opportunities2017 - 2025

Global Atrial Septal Defect Market: Outlook

Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole is referred to as atrial septal defect. Huge and long-term atrial septal defects may lead to serious heart and lung damage. In some cases, extra blood volume can overfill the lungs and increases the blood pressure of the lungs, leading to pulmonary hypertension. Most of the congenital heart diseases are caused by certain genetic defects. The three most common types of atrial septal defects are ostium secundum atrial septal defect, ostium primum atrial septal defect and sinus venosus atrial septal. Various

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17066

symptoms associated with atrial septal defect are as follows:

Difficulty in breathing (dyspnea)
Frequent respiratory infections
Swelling of legs and feet
Heart palpitations
Fatigue

Global Atrial Septal Defect Market: Key Segments

Based on diagnosis, the atrial septal defect market can be segmented as follows:

Electrocardiogram (ECG): ECG records the electrical activity of an individual and identifies heart problems
Chest X-ray: With the help of X-ray, condition of the heart and lungs are detected
Cardiac catheterization: In this test, a catheter is inserted into the heart via vein and any congenital heart defects can be diagnosed including amount of oxygen in the blood
Transesophageal echocardiography (TEE): The test provides an ultrasound image to provide a clearer image of the atria
Pulse oximetry: This test helps to detect whether oxygenated blood is mixing with deoxygenated blood, thereby confirming any type of heart defect

The medications which are used to reduce the signs and symptoms of atrial septal defect include beta blockers (Lopressor, Inderal), anticoagulants (Coumadin) and anti-platelet agents (aspirin). In some instances, surgery is also done to repair an atrial septal defect such as open-heart surgery and cardiac catheterization.

Request For Discount On This Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=17066

Global Atrial Septal Defect Market: Regional Analysis

Based on geography, the atrial septal defect market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these regions, North America holds a leading position in the market followed by Europe. The prime factors which are driving the growth of atrial septal defect market in these regions are high prevalence of genetic heart disorders, and growing awareness of the population regarding atrial septal defects. Moreover, technological advancement in the treatment of congenital heart diseases is also accentuating the growth of the market. Asia Pacific is the most lucrative market for the growth of atrial septal defect market. The advantageous factors which would propel the growth of the market in Asia Pacific are presence of large population base and emerging economies such as China, Malaysia, India and Vietnam. Furthermore, favorable reimbursement policies and increasing disposable income of the Asian population would further boost the growth of atrial septal defect market in the coming years.

View Report: https://www.transparencymarketresearch.com/atrial-septal-defect-market.html

Global Atrial Septal Defect Market: Companies Mentioned in the Report

Various pharmaceutical companies are constantly trying to come up with novel therapeutic developments for the treatment of atrial septal defect. Some of the top major players operating in the atrial septal defect market are Asklepion Pharmaceuticals, LLC, Actelion Ltd., Novo Nordisk A/S, Abbott Laboratories, INO Therapeutics, LLC and others.

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Septal Defect Market Future Opportunities2017 - 2025 here

News-ID: 1019330 • Views: 219

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for Atrial

Atrial Fibrillation Device Market Latest Trends and Forecast Analysis - 2026
Atrial fibrillation is a type of arrhythmias refers to as an irregular heart rhythm of the upper chamber of the heart i.e. erratically change of normal sequence electrical impulses. Atrial fibrillation is treated with medications by slowing the heart rate to the rhythm control stage. Atrial fibrillation may lead to blood cloth, heart failure, strokes and other heart related problems. If atrial fibrillation disease remains untreated it will double the
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Fibrillation - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Atrial Fibrillation - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation - Pipeline Review, H2 2017, provides an overview of the Atrial Fibrillation (Cardiovascular) pipeline landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body.
Atrial Fibrillation Market – Global Industry Insights 2024
Atrial fibrillation or A-fib or AF is an irregular heart beat exemplified by rapid and abnormal beating of the heart. The process usually starts as short periods of uncharacteristic beating that become elongated and constant over a period of time. Most episodes have little or no symptoms. Intermittently there can be palpitations in the heart, lightheadedness, fainting, chest pain, or shortness of breath, among others. Atrial fibrillation is linked with